Gyeonggi-do, South Korea

Ha Na Cho


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ha Na Cho - Innovator in Drug Delivery Systems

Introduction

Ha Na Cho is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on polynucleotide polymers. Her research focuses on enhancing the efficacy of drug delivery mechanisms, which is crucial for advancing medical treatments.

Latest Patents

Ha Na Cho holds a patent for a "Reducing or non-reducing polynucleotide polymer for drug delivery and method for preparing same." This invention relates to a polynucleotide polymer synthesized using nucleotides such as AMP, ADP, ATP, GMP, GDP, GTP, CMP, CDP, and CTP, along with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxy-succinimide (NHS). The polymer serves as a drug delivery carrier that utilizes electrostatic attraction to deliver proteins or peptides to targeted areas. The polymer is designed to be easily breakable due to disulfide bonds, enhancing its effectiveness in drug delivery.

Career Highlights

Ha Na Cho is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. Her work in this institution has allowed her to collaborate with other researchers and contribute to advancements in drug delivery technologies.

Collaborations

Some of her notable coworkers include Han Chang Kang and You Han Bae, who have also contributed to the research and development of innovative drug delivery systems.

Conclusion

Ha Na Cho's work in developing polynucleotide polymers for drug delivery represents a significant advancement in medical technology. Her innovative approach has the potential to improve the effectiveness of drug therapies, making her a key figure in the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…